CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

Guidance for including elderly patients in clinical trials

Older adults shoulder a disproportionate burden of chronic diseases and consumption of prescription drugs. Nevertheless, older adults, especially those aged over 75 years, are chronically under-represented in clinical trials. In this two part series, Dr Kiri Granger explores the risks of under-presentation and outlines guidance for including older adults in clinical trials.

Read on for session two: key design considerations when including elderly patients in clinical trials, with a focus on cognitive assessment.  

Why are elderly patients under-represented in clinical trials?

Older adults are consistently under-represented in clinical trials, even though they take more prescription medications than any other group. In this two part series, Dr Kiri Granger will explore this under-presentation and outline practical considerations for including older adults in clinical trials.

Read on for session one: the importance of addressing the evidence-practice gap.  

Assessment of cognitive safety in clinical drug development

Published in Drug Discovery Today, our keynote review outlines the rationale, study design, and methods for cognitive safety assessment during clinical drug development. 

web-based testing, wearables, voice recognition, voice, virtual clinical trials, technology, swm, subjective measures, stigma, social cognition, smartphones, schizophrenia research, schizophrenia, safety, research funding, research, remote testing, regulations, recruitment, rare disease, psychosis, prodromal, pro-cognitive, press release, presenteeism, precision psychiatry, pre-clinical, poster, personalised medicine, patient recruitment, parkinson's disease, pal, paired associates learning, ots, occupational health, objective measures, normative data, neurotech, neuroscience, near-patient testing, multiple sclerosis, ms, modelling, mental wellbeing, mental health at work, mdd, mci, major depression, longitudinal, hot cognition, high-frequency testing, high frequency, healthcare, funding, fatigue, ert, epidemiology, ecoa, ebt, ebbinghaus, early career researchers, early alzheimer's disease, drug development, digital tools, digital health, depression, dementia, covid-19, cognitive wellbeing, cognitive testing, cognitive science, cognitive safety, cognitive research, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, chronic illness, chronic health conditions, cgt, cantab testimonial, cantab research grant, cantab for clinical trials, cantab, brain health, biomarkers, awards, autism, asd, alzheimer's disease, affective cognition, absenteeism,